An interventional study of Realibility in Disorder and Kyphosis Deformity of Thoracic Spine, sponsored by Gaziantep Islam Science and Technology University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-02.
Sponsored by Gaziantep Islam Science and Technology University · Not applicable, Interventional, and Other
The presedent study evaluates intra-rater and inter-rater reliability of the Smartphone inclinometer app and the flexicurve, on the thoracic kyphosis
Sixty subjects ranging from 17to 24 years of age were evaluated by two independent evaluators using the Flexicurve and the Smartphone inclinometer app to measure thoracic kyphosis
1,327 studies on the registry are indexed under Disease; 596 are open to participants now.
This study's enrollment of 60 is below the median of 80 across 732 interventional studies indexed under Disease.
Browse Disease studies →Gaziantep Islam Science and Technology University is the lead sponsor of 39 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Measurement of thoracic kyphosis
Other: Realibility
measurement of the thoracic kyphosis with flexicurve and Smartphone inclinometer app
Also known as: İntra rater and inter rater
İntra-İnterrater reliability fleksicurve and smartphone inclinometer app on thoracic kyphosis
60 participant (35 male, 25 female) who have over 30 degree thoracic kyphosis were evaluated by two raters for finding correlation between flexicurve and smartphone inclinometer app.
Time frame: 1 Year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gaziantep Islam Science and Technology University